About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Bladder Cancer
›
top-articles
Bladder Cancer
0.7
(top 50%)
impact factor
368
(top 50%)
papers
3.2K
(top 20%)
citations
29
(top 20%)
h
-index
0.7
(top 50%)
impact factor
422
all documents
3.5K
doc citations
42
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting
Bladder Cancer
2016
184
2
A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer
Bladder Cancer
2016
79
3
Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG
Bladder Cancer
2015
75
4
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)
Bladder Cancer
2016
73
5
Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
Bladder Cancer
2015
69
6
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
Bladder Cancer
2017
60
7
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
Bladder Cancer
2018
58
8
Micropapillary Bladder Cancer: Insights from the National Cancer Database
Bladder Cancer
2016
56
9
The BCG Shortage
Bladder Cancer
2017
55
10
Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
Bladder Cancer
2018
55
11
Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States
Bladder Cancer
2018
55
12
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
Bladder Cancer
2016
46
13
Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder Cancer
Bladder Cancer
2016
45
14
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression
Bladder Cancer
2016
44
15
Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol
Bladder Cancer
2017
43
16
Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
Bladder Cancer
2017
41
17
Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
Bladder Cancer
2018
41
18
Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life Instruments
Bladder Cancer
2016
40
19
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation
Bladder Cancer
2018
40
20
Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
Bladder Cancer
2017
39
21
The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
Bladder Cancer
2016
38
22
The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors
Bladder Cancer
2016
34
23
A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma
Bladder Cancer
2016
34
24
Systematic Review: Targeting HER2 in Bladder Cancer
Bladder Cancer
2019
34
25
Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis
Bladder Cancer
2018
33
26
Urinary Biomarkers in the Evaluation of Primary Hematuria: A Systematic Review and Meta-Analysis
Bladder Cancer
2018
33
27
Bladder Cancer Genetic Susceptibility. A Systematic Review
Bladder Cancer
2018
33
28
Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
Bladder Cancer
2016
32
29
Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy
Bladder Cancer
2016
31
30
Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
Bladder Cancer
2016
30
31
Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Bladder Cancer
2017
30
32
Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?
Bladder Cancer
2017
30
33
Pursuing Quality in the Application of Bladder Cancer Quality of Life Research
Bladder Cancer
2016
29
34
Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer
Bladder Cancer
2016
29
35
Antibody-Drug Conjugates in Bladder Cancer
Bladder Cancer
2018
29
36
Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome
Bladder Cancer
2018
28
37
Image-Guided Transurethral Resection of Bladder Tumors – Current Practice and Future Outlooks
Bladder Cancer
2017
27
38
Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies
Bladder Cancer
2018
27
39
Early Complications and Mortality following Radical Cystectomy: Associations with Malnutrition and Obesity
Bladder Cancer
2018
26
40
Transversus Abdominis Plane Blockade as Part of a Multimodal Postoperative Analgesia Plan in Patients Undergoing Radical Cystectomy
Bladder Cancer
2018
26
41
Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients
Bladder Cancer
2018
26
42
Treatment Decision Making in Patients with Bladder Cancer
Bladder Cancer
2015
25
43
Limited Funds for Bladder Cancer Research and What Can We Do About It
Bladder Cancer
2016
25
44
Bladder Preservation for Muscle Invasive Bladder Cancer
Bladder Cancer
2016
25
45
Circulating Biomarkers in Bladder Cancer
Bladder Cancer
2016
25
46
Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response
Bladder Cancer
2016
24
47
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer
Bladder Cancer
2016
24
48
Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients
Bladder Cancer
2017
24
49
Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions
Bladder Cancer
2017
24
50
The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial Carcinoma
Bladder Cancer
2016
23
site/software ©
exaly
; All materials licenced under
CC by-SA
.